- Home
- INDO vs CODX Comparison
INDO vs CODX Comparison
Compare INDO & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDO
- CODX
- Stock Information
- Founded
- INDO 2018
- CODX 2013
- Country
- INDO Indonesia
- CODX United States
- Employees
- INDO N/A
- CODX N/A
- Industry
- INDO Oil & Gas Production
- CODX Medical/Dental Instruments
- Sector
- INDO Energy
- CODX Health Care
- Exchange
- INDO Nasdaq
- CODX Nasdaq
- Market Cap
- INDO 40.1M
- CODX 39.3M
- IPO Year
- INDO 2019
- CODX 2017
- Fundamental
- Price
- INDO $2.78
- CODX $0.75
- Analyst Decision
- INDO
- CODX Hold
- Analyst Count
- INDO 0
- CODX 1
- Target Price
- INDO N/A
- CODX $1.50
- AVG Volume (30 Days)
- INDO 445.6K
- CODX 155.7K
- Earning Date
- INDO 12-27-2024
- CODX 11-07-2024
- Dividend Yield
- INDO N/A
- CODX N/A
- EPS Growth
- INDO N/A
- CODX N/A
- EPS
- INDO N/A
- CODX N/A
- Revenue
- INDO $3,127,587.00
- CODX $7,321,012.00
- Revenue This Year
- INDO N/A
- CODX N/A
- Revenue Next Year
- INDO N/A
- CODX N/A
- P/E Ratio
- INDO N/A
- CODX N/A
- Revenue Growth
- INDO N/A
- CODX 57.16
- 52 Week Low
- INDO $2.03
- CODX $0.75
- 52 Week High
- INDO $6.65
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- INDO 37.95
- CODX 27.16
- Support Level
- INDO $2.62
- CODX $0.73
- Resistance Level
- INDO $3.09
- CODX $0.87
- Average True Range (ATR)
- INDO 0.16
- CODX 0.06
- MACD
- INDO 0.01
- CODX -0.00
- Stochastic Oscillator
- INDO 12.50
- CODX 16.67
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.